SIGA Technologies (NASDAQ:SIGA) Trading Up 10.5% – Here’s What Happened

Posted by Anthony Miller on Nov 27th, 2024

SIGA Technologies, Inc. (NASDAQ:SIGA – Get Free Report)’s stock price was up 10.5% during trading on Monday . The company traded as high as $7.21 and last traded at $7.16. Approximately 555,769 shares were traded during mid-day trading, a decline of 37% from the average daily volume of 877,156 shares. The stock had previously closed at $6.48.

SIGA Technologies Trading Up 4.7 %

The business’s 50 day simple moving average is $6.99 and its two-hundred day simple moving average is $7.85. The firm has a market capitalization of $525.50 million, a PE ratio of 6.13 and a beta of 0.89.

SIGA Technologies (NASDAQ:SIGA – Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.02 EPS for the quarter. The company had revenue of $10.01 million during the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. As a group, equities research analysts anticipate that SIGA Technologies, Inc. will post 1.04 earnings per share for the current year.

Institutional Trading of SIGA Technologies

Large investors have recently added to or reduced their stakes in the business. Larson Financial Group LLC bought a new stake in shares of SIGA Technologies during the 3rd quarter valued at $30,000. DekaBank Deutsche Girozentrale purchased a new position in SIGA Technologies during the second quarter valued at $40,000. EP Wealth Advisors LLC bought a new stake in SIGA Technologies during the third quarter valued at about $82,000. XTX Topco Ltd purchased a new stake in SIGA Technologies in the third quarter worth about $85,000. Finally, China Universal Asset Management Co. Ltd. raised its stake in shares of SIGA Technologies by 64.3% in the third quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock worth $93,000 after buying an additional 5,372 shares during the period. 55.40% of the stock is currently owned by institutional investors.

SIGA Technologies Company Profile

(Get Free Report)

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.